Molecular therapy oncolytics

Federal government websites often end in. The site is secure. Their timing was right on, as it was concurrent with the first FDA approval of an anti-PD-1 molecular therapy oncolytics, and the following year, we saw the first FDA approval of an oncolytic virus as a cancer therapy.

View the family homepage Submit Your Research. ASGCT members receive online subscriptions to the Molecular Therapy journals to stay up to date on the latest research in the field. Here's how to claim your subscription:. Claim Your Subscription. MT is dedicated to publishing important peer-reviewed research and cutting-edge reviews and commentaries promoting genetics, medicine, and biotechnology.

Molecular therapy oncolytics

Cell Press. How to publish in this journal. The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 green comprises the quarter of the journals with the highest values, Q2 yellow the second highest values, Q3 orange the third highest values and Q4 red the lowest values. The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is. Evolution of the number of published documents. All types of documents are considered, including citable and non citable documents. This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal.

Year SJR 0.

.

Oncolytic viruses mediate antitumor responses through direct tumor cell lysis and induction of host antitumor immunity. However, the therapeutic efficacy of oncolytic viruses against malignant ascites has rarely been explored. This study aimed to evaluate the efficacy, safety, and immunomodulatory effect of an intraperitoneal injection of human type 5 recombinant adenovirus called H against malignant ascites. Forty patients with malignant ascites were recruited and treated with intraperitoneal H in the Fudan University Shanghai Cancer Center. The 4-week clinical responses were determined by an objective assessment of ascites volume change. Hmeditated tumor-specific immune activation on day 14 post-treatment was further identified by enzyme-linked immunospot assay. In conclusion, intraperitoneal H administration was well tolerated and effective in treating malignant ascites; thus, its immune activation ability may be a promising tool in combination with immunotherapy.

Molecular therapy oncolytics

Application in antiviral discovery and disinfection procedures. Conventional cancer treatments have limited effectiveness in many cases. Oncolytic therapy, based on the use of armed viruses directed against tumor cells, offers new perspectives in the fight against this global scourge. Using autofluorescent viruses, we can measure the impact of the presence of a molecule of interest on virus infection and replication capacities. Our technology allows us to quickly calibrate and validate the development of disinfection devices. We can offer different types of imaging and also image analysis whether in a viral or non-viral context, from high content imaging to high resolution imaging and light sheet microscopy.

Tips palafrugell

Year International Collaboration Here's how to submit a request. Contact the editors-in-chief of each journal as well as Cell Press communications and advertising staff here. Read Statements. Please check our website periodically for our call for volunteers to see the topic areas we seek to fill. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is. Cell Press. This site uses cookies to offer you a better user experience and to analyze site traffic. Cancer Discov. Zamecnik A. Documents Year Value Uncited documents 0 Uncited documents 2 Uncited documents 12 Uncited documents 10 Uncited documents 16 Uncited documents 12 Uncited documents 7 Uncited documents 17 Uncited documents 42 Cited documents 0 Cited documents 4 Cited documents 16 Cited documents 56 Cited documents 78 Cited documents 89 Cited documents Cited documents Cited documents

.

The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. View Current Issue. Editorial Contacts Contact the editors-in-chief of each journal as well as Cell Press communications and advertising staff here. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address. First Oncolytic Viral Therapy for Melanoma. This site uses cookies to offer you a better user experience and to analyze site traffic. Timothy P. Friedman G. Cell Press. Evolution of the number of total citation per document and external citation per document i.